搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pyrococcus horikoshii Pyruvoyl-dependent arginine decarboxylase (pdaD) CSB-YP523928FHX
CSB-EP523928FHX
CSB-BP523928FHX
CSB-MP523928FHX
CSB-EP523928FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Peptide chain release factor subunit 1 (prf1) CSB-YP523929FHX
CSB-EP523929FHX
CSB-BP523929FHX
CSB-MP523929FHX
CSB-EP523929FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Probable thermostable DNA ligase (lig), partial CSB-YP523930FHX
CSB-EP523930FHX
CSB-BP523930FHX
CSB-MP523930FHX
CSB-EP523930FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii 30S ribosomal protein S9P (rps9p) CSB-YP523931FHX
CSB-EP523931FHX
CSB-BP523931FHX
CSB-MP523931FHX
CSB-EP523931FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Signal recognition 54 kDa protein (srp54) CSB-YP523932FHX
CSB-EP523932FHX
CSB-BP523932FHX
CSB-MP523932FHX
CSB-EP523932FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii UPF0173 metal-dependent hydrolase PH1671 (PH1671) CSB-YP523933FHX
CSB-EP523933FHX
CSB-BP523933FHX
CSB-MP523933FHX
CSB-EP523933FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Probable tRNA pseudouridine synthase B (truB) CSB-YP523934FHX
CSB-EP523934FHX
CSB-BP523934FHX
CSB-MP523934FHX
CSB-EP523934FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP523935FHX
CSB-EP523935FHX
CSB-BP523935FHX
CSB-MP523935FHX
CSB-EP523935FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii tRNA wyosine derivatives biosynthesis protein Taw1 (taw1) CSB-YP523936FHX
CSB-EP523936FHX
CSB-BP523936FHX
CSB-MP523936FHX
CSB-EP523936FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii 50S ribosomal protein L22P (rpl22p) CSB-YP523937FHX
CSB-EP523937FHX
CSB-BP523937FHX
CSB-MP523937FHX
CSB-EP523937FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii 30S ribosomal protein S4e (rps4e) CSB-YP523938FHX
CSB-EP523938FHX
CSB-BP523938FHX
CSB-MP523938FHX
CSB-EP523938FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii 50S ribosomal protein L18P (rpl18p) CSB-YP523939FHX
CSB-EP523939FHX
CSB-BP523939FHX
CSB-MP523939FHX
CSB-EP523939FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Protein translocase subunit SecY (secY), partial CSB-YP523940FHX
CSB-EP523940FHX
CSB-BP523940FHX
CSB-MP523940FHX
CSB-EP523940FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii tRNA (Ile2) 2-agmatinylcytidine synthetase TiaS CSB-YP523941FHX
CSB-EP523941FHX
CSB-BP523941FHX
CSB-MP523941FHX
CSB-EP523941FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Non-canonical purine NTP pyrophosphatase (PH1917) CSB-YP523942FHX
CSB-EP523942FHX
CSB-BP523942FHX
CSB-MP523942FHX
CSB-EP523942FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Enolase (eno) CSB-YP523943FHX
CSB-EP523943FHX
CSB-BP523943FHX
CSB-MP523943FHX
CSB-EP523943FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Histidinol dehydrogenase (hisD) CSB-YP523944FHW
CSB-EP523944FHW
CSB-BP523944FHW
CSB-MP523944FHW
CSB-EP523944FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Modification methylase MwoI (mwoIM), partial CSB-YP523945MRQ
CSB-EP523945MRQ
CSB-BP523945MRQ
CSB-MP523945MRQ
CSB-EP523945MRQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe LisH domain-containing protein C29A3.03c (SPBC29A3.03c) CSB-YP523946SXV
CSB-EP523946SXV
CSB-BP523946SXV
CSB-MP523946SXV
CSB-EP523946SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized mitochondrial carrier C29A3.11c (SPBC29A3.11c), partial CSB-YP523947SXV1
CSB-EP523947SXV1
CSB-BP523947SXV1
CSB-MP523947SXV1
CSB-EP523947SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>